Your science and technology news reporter from the country of Georgia

Provided by AGP

Georgian Technology News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Georgian Technology News.

Press releases published on May 19, 2026

Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
DevRev Appoints General Richard Clarke to Board of Directors
Microchip Technology to Present at the JP Morgan 2026 Global Technology, Media and Communications Conference
BlackLine Announces Participation in Upcoming Investor Conferences
HP Inc. Declares Dividend
Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants
iRhythm Holdings to Participate in Upcoming Investor Conferences
Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
Relay Therapeutics Announces Proposed Public Offering of Common Stock
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit
Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
Kasi Cloud Datacenters Commissions West Africa's First Hyperscale-Ready, AI-Capable Data Centre Campus in Lagos
Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity
Ipsen annonce des données « late-breaking » issues de la première étude comparative directe entre Dysport® et Botox® chez des adultes atteints de spasticité du membre supérieur
Oorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic Diseases

Share us

on your social networks:

Sign up for:

Georgian Technology News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.